Represented Vertos Medical, Inc. in its $23 million Series E Financing. The financing was led by Pitango Venture Capital and included existing investors, ONSET Ventures, CHL Medical Partners, Foundation Medical Partners, Mercury Fund and Aweida Venture Partners. The money raised will be used to fund U.S. commercialization and the launch of the mild® procedure in European Markets.
Vertos Medical developed the mild® procedure, an outpatient procedure designed to help patients diagnosed with lumbar spinal stenosis stand longer and walk father with less pain. The mild® procedure has a positive response rate of 81 percent. Read the press release.